Performance of Pharmaceutical Industry Stocks in Indian Market: An Empirical Analysis

The Indian Pharmaceutical Market (IPM) represents in terms of prices, 3% of the international pharmaceutical industry and in terms of volume, 20%. Several MNC companies have an active presence in the Indian pharmaceutical space due to robust historical production. The study is based primarily on secondary data and it used four year data from 1st January 2014 to 31st December 2017. Five companies’ stocks are selected for the study i.e. Dr. Reddy‘s Labs, Cipla ,Lupin , AurobindoPharma and Sun pharma. It was found that Pharmaceutical companies have a negative relationship with the Nifty index.It was also found that the pharmaceutical companies and the nifty themselves were that in the stock price level but there are variations in the pharmaceutical companies ' costs.